snmjournals.org

PSMA PET Evaluation with a Deep Learning Platform Compared with a Standard Image Viewer and Histopathology

Standardized prostate-specific membrane antigen (PSMA) PET/CT evaluation and reporting was introduced to aid interpretation, reproducibility, and communication. Artificial intelligence may enhance ...
snmjournals.org

PSMA PET Evaluation with a Deep Learning Platform Compared with a Standard Image Viewer and Histopathology

Journal of Nuclear Medicine October 2025, jnumed.125.270242; DOI: https://doi.org/10.2967/jnumed.125.270242 ...
snmjournals.org

Fully Automated Image-Based Multiplexing of Serial PET/CT Imaging for Facilitating Comprehensive Disease Phenotyping

Journal of Nuclear Medicine September 2025, jnumed.125.269688; DOI: https://doi.org/10.2967/jnumed.125.269688 ...
snmjournals.org

Prognostic Value of Comprehensive Analysis of Metastatic Prostate Tumor Changes from First to Last

Journal of Nuclear Medicine September 2025, jnumed.125.270358; DOI: https://doi.org/10.2967/jnumed.125.270358 ...
snmjournals.org

Evaluating Radiotheranostic Targets for Endometrial Cancer

Journal of Nuclear Medicine August 2025, jnumed.125.270318; DOI: https://doi.org/10.2967/jnumed.125.270318 ...
snmjournals.org

Monitoring T-Cell Activation in the Tumor Microenvironment by PET Imaging of the Chemokine CXCL9

Journal of Nuclear Medicine August 2025, jnumed.125.269795; DOI: https://doi.org/10.2967/jnumed.125.269795 ...
snmjournals.org

Lymphoma Therapy Response Assessment with Low-Dose

Journal of Nuclear Medicine August 2025, jnumed.124.268841; DOI: https://doi.org/10.2967/jnumed.124.268841 ...
snmjournals.org

Differential Association of PET-Derived Rest and Stress Myocardial Blood Flow with Cardiovascular Outcomes

Journal of Nuclear Medicine June 2025, jnumed.125.269457; DOI: https://doi.org/10.2967/jnumed.125.269457 Patients were scanned using the Biograph Vision digital PET ...
snmjournals.org

225 Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2–Expressing Breast Cancer

Radioimmunotherapy using 225Ac, a highly cytotoxic α-particle emitter, has potential for treating advanced breast cancer, especially human epidermal growth factor receptor 2 (HER2)–positive cases. We ...
snmjournals.org

GPC3-targeted immunoPET allows for early detection of HCC: a pilot clinical study

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 252173; ...
snmjournals.org

Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis

Journal of Nuclear Medicine May 2025, jnumed.124.269227; DOI: https://doi.org/10.2967/jnumed.124.269227 ...
snmjournals.org

PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy

Despite well-documented limitations, current guidelines recommend the use of size-based RECIST 1.1 for response assessment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) under ...